Table 2.
Multivariate analysis: Risk of new PM implantation by TAVI year
| OR | 95% CI | P Value | |
|---|---|---|---|
| TAVI calendar year as a continuous measure | |||
| Per 1‐year increment | 0.81 | 0.70‐0.94 | 0.004 |
| TAVI period categorized by quintiles | |||
| Q1: 2008–2010 | Ref | ||
| Q2: 2011 | 0.54 | 0.28‐1.02 | 0.057 |
| Q3: 2012 | 0.69 | 0.37‐1.26 | 0.221 |
| Q4: 2013 | 0.23 | 0.10‐0.50 | <0.001 |
| Q5: 2014 | 0.50 | 0.26‐0.97 | 0.039 |
Abbreviations: AF, atrial fibrillation; CI, confidence interval; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; LVEF, left ventricular ejection fraction; OR, odds ratio; PCI, percutaneous coronary intervention; PM, pacemaker; Q, quintile; Ref, reference; STS, Society of Thoracic Surgeons; TAVI, transcatheter aortic valve implantation.
Adjusted for age, sex, LVEF, STS score, DM, AF, COPD, baseline mean transaortic gradient, and history of PCI and mitral valve replacement.